Journal profile · Endocrinology & Metabolism
Endocrine Reviews
ISSN 0163-769X · eISSN 1945-7189 · The Endocrine Society · UNITED STATES · Bimonthly · Founded 1980
Endocrine Reviews: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 23.82; hybrid open access; APC about USD 3,750; median 181 days to acceptance (43 articles, last 24 months); community-reported acceptance: mostly invited papers; 44 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Endocrine Reviews is published by The Endocrine Society and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Estrogen and related hormone effects, Growth Hormone and Insulin-like Growth Factors and Thyroid Disorders and Treatments, together about 26% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endocrine Reviews publishes authoritative review articles spanning experimental and clinical endocrinology. The Editors of Endocrine Reviews will consider topics on emerging and established clinical research as well as advances in endocrine science emanating from studies of cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Ashley GrossmanPublisher website
Editorial board by country: none in mainland China; most named United States 6, United Kingdom 2, India 2, Sri Lanka 2, Australia 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology10.3%
- Growth Hormone and Insulin-like Growth FactorsMedicine10.2%
- Thyroid Disorders and TreatmentsMedicine5.5%
- Pancreatic function and diabetesMedicine5.3%
- Pituitary Gland Disorders and TreatmentsMedicine4.5%
- Hormonal Regulation and HypertensionMedicine4.5%
- Adipose Tissue and MetabolismMedicine4.3%
- Hypothalamic control of reproductive hormonesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 23.82LetPub ·
- Impact factor (publisher) 2025
- 56.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 34.1Publisher website ·
- CiteScore 2026-06
- 56.5LetPub ·
- CiteScore (publisher) 2025
- 56.5Publisher website ·
- SJR 2026-06
- 9.99LetPub ·
- SNIP 2026-06
- 11.03LetPub ·
- h-index
- 257LetPub ·
- h-index
- 429OpenAlex ·
- i10-index
- 1,718OpenAlex ·
- 2-year mean citedness
- 21.06OpenAlex ·
- Self-citation rate
- 0.4%LetPub ·
- Share of gold OA articles
- 51.89%LetPub ·
Volume
- Articles per year
- 39LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Downloads per year (publisher) 2025
- 1,326,913Publisher website ·
Articles by year OpenAlex count · 2,496 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 16 | 27 |
| 2025 | 44 | 33 | 711 |
| 2024 | 33 | 28 | 1,642 |
| 2023 | 37 | 34 | 2,788 |
| 2022 | 35 | 30 | 4,862 |
| 2021 | 47 | 43 | 6,716 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
181 daysMedian, submission to acceptance · P25–P75 142 days – 257 days
- Acceptance to online
- median 7 days (19 articles)
- Submission to online
- median 187 days
- Sample
- 43 articles with submission and acceptance dates (95 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,750 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- The Endocrine Society
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1980
- ISSN
- 0163-769X
- Electronic ISSN
- 1945-7189
- Latest issue on the website
- Volume 47, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Endocrine Reviews
What CAS zone is Endocrine Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endocrine Reviews is in Zone 1 of Medicine, and in Zone 1 of the minor category Endocrinology & Metabolism; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endocrine Reviews?
The latest impact factor listed by LetPub is 23.82; CiteScore 56.5, h-index 429.
How long does peer review take at Endocrine Reviews?
Based on the dates recorded on 43 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 181 days (interquartile range 142–257 days); the community-reported acceptance is “Mostly invited papers”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Endocrine Reviews based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (6), United Kingdom (2) and India (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrine Reviews?
According to LetPub and DOAJ records, Endocrine Reviews is indexed in SCIE and Scopus.
Is Endocrine Reviews open access, and what is the APC?
Endocrine Reviews is a hybrid journal. For open-access publication: APC about USD 3,750.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .